Literature DB >> 33928580

ITC for Characterization of Self-Assembly Process of Cationic Dendrons for siRNA Delivery.

Erik Laurini1, Suzana Aulic2, Natasa Skoko3, Domenico Marson2, Maurizio Fermeglia2, Sabrina Pricl2,4.   

Abstract

siRNAs are emerging as promising therapeutic agents due to their ability to inhibit specific genes in many diseases. However, these tools require specific vehicles in order to be safely delivered to the targeted site. Among different siRNA delivery systems, self-assembled nanomicelles based on amphiphilic cationic dendrons (ACDs) have recently outperformed nanovectors based on covalent carriers. This chapter describes how isothermal titration calorimetry (ITC) can be exploited as one of the best techniques to investigate the self-assembly process of ACDs. Specifically, ITC can provide, as such or via specific analysis methods, a full thermodynamic characterization of these nanomicelles, including their critical micellar concentration, micelle aggregation number, degree of counterion binding, Gibbs free energy of micellization, and its enthalpic and entropic components.

Keywords:  Amphiphilic cationic dendrons; Critical micelle concentration; Isothermal titration calorimetry; Micelles; Self-assembly; siRNA delivery

Year:  2021        PMID: 33928580     DOI: 10.1007/978-1-0716-1298-9_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

Review 1.  Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.

Authors:  Jianfeng Guo; Karen A Fisher; Raphael Darcy; John F Cryan; Caitriona O'Driscoll
Journal:  Mol Biosyst       Date:  2010-04-29

Review 2.  Lipid-based nanoparticles for nucleic acid delivery.

Authors:  Weijun Li; Francis C Szoka
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 3.  Nonviral in vivo delivery of therapeutic small interfering RNAs.

Authors:  Achim Aigner
Journal:  Curr Opin Mol Ther       Date:  2007-08

Review 4.  Efficient siRNA delivery with non-viral polymeric vehicles.

Authors:  Won Jong Kim; Sung Wan Kim
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

Review 5.  The current state and future directions of RNAi-based therapeutics.

Authors:  Ryan L Setten; John J Rossi; Si-Ping Han
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

6.  An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo.

Authors:  Tianzhu Yu; Xiaoxuan Liu; Anne-Laure Bolcato-Bellemin; Yang Wang; Cheng Liu; Patrick Erbacher; Fanqi Qu; Palma Rocchi; Jean-Paul Behr; Ling Peng
Journal:  Angew Chem Int Ed Engl       Date:  2012-07-24       Impact factor: 15.336

Review 7.  RNAi and small interfering RNAs in human disease therapeutic applications.

Authors:  Monica R Lares; John J Rossi; Dominique L Ouellet
Journal:  Trends Biotechnol       Date:  2010-09-15       Impact factor: 19.536

8.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

9.  Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine.

Authors:  Klaus Kunath; Anke von Harpe; Dagmar Fischer; Holger Petersen; Ulrich Bickel; Karlheinz Voigt; Thomas Kissel
Journal:  J Control Release       Date:  2003-04-14       Impact factor: 9.776

Review 10.  Targeted therapy of cancer: new roles for pathologists--prostate cancer.

Authors:  Mark A Rubin
Journal:  Mod Pathol       Date:  2008-05       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.